OG article  by QuocTuan Nguyen 1, SunHyeong Choi 1, HongDa Yun 1,2, YoungMi Lee1, ChulMin Kim 3, SeoJeong Oh 4, ManSoo Cho5, EunSol Lee 6, JungWon Seo 6 and HyunJu Jung 1 January 15, 2026 A study in Records of Natural Products isolated bioactive compounds from the flowers of Cannabis sativa L., including a new alkaloid and known cannabinoids/sesquiterpenoids, evaluating their biological activities. From ethanolic extracts' n-hexane fraction, eight compounds were obtained, wit

OG article  by Anthony Martinelli January 15, 2026 Research published in Plants suggests that hemp seed extracts can enhance the effectiveness of certain antibiotics and antifungal medications, with results varying by cultivar and extraction technique. Scientists from Victor Babes University of Medicine and Pharmacy tested three Romanian hemp varieties—Lovrin 110, Silvana, and LV 585—using hydroalcoholic and ultrasound-assisted extraction methods. Ultrasound extraction produc

OG article  by Anthony Martinelli January 15, 2026 A study in the Journal of Psychoactive Drugs by researchers from the University at Buffalo links cannabis-infused beverage consumption to reduced alcohol use and fewer binge drinking episodes. Survey data from 438 adults who used marijuana in the past year compared patterns between those who consumed cannabis beverages (33.6%, typically one per session) and non-users. Beverage users were more likely to substitute cannabis for

OG article  by CBT Staff January 15, 2026 Circle K has become the first major convenience store chain in Texas to offer hemp-derived THC beverages, now available in dozens of locations throughout the Dallas-Fort Worth area through a partnership with VARIN. These innovative drinks feature hemp-derived THC combined with functional ingredients such as CBDV, theobromine, L-theanine, lion's mane, and vitamin B-12, delivering a jitter-free, euphoric experience free of caffeine, sug

OG article by Anthony Martinelli January 15, 2026 A randomized, placebo-controlled, crossover clinical trial published in Nutrients found that a single 300 mg dose of cannabidiol (CBD) may reduce anxiety and perceived effort during exercise in recreational runners. The study involved 12 participants (average age 25.5) who ingested CBD or placebo capsules, rested for two hours, then completed a 2-mile treadmill run at maximum effort. Assessments measured state anxiety, relaxa

OG article by Anthony Martinelli January 15, 2026 A laboratory study published in the journal Molecules demonstrates that cannabidiol (CBD) possesses potent antibacterial activity against drug-resistant strains of Enterococcus bacteria. Researchers from Nicolaus Copernicus University and Wrocław University of Environmental and Life Sciences evaluated five commercial CBD oil products alongside 99% pure CBD crystals against 20 clinical isolates of Enterococcus faecalis and Ent

OG article by Alex Barton January 15, 2026 Missouri State Rep. Matthew Overcast (R-Douglas County) introduced House Joint Resolution 106 to amend the state constitution, repealing current marijuana laws for a less restrictive framework. It removes possession limits, allows adults 21+ to possess, use, and grow unlimited marijuana/hemp, and bars state criminalization or control. Home cultivation permits up to 30 plants in secure areas. Medical access expands to ages 18+ with s

OG article by Carl Campanile January 15, 2026 New York Gov. Kathy Hochul proposes the nation's first "Center for Excellence for Cannabis Care and Health Equity" to boost medical marijuana access in minority communities, where recreational dispensaries outnumber medical ones. Partnering with medical schools, it will train clinicians on cannabis pharmacology, evidence-based care, and counseling—areas often missing from education—and may license trained providers. Hochul highli

OG article by Tom Angell January 15, 2026 Republican Senators Ted Budd (R-NC) and James Lankford (R-OK) filed an amendment blocking the Justice Department from using Fiscal Year 2026 funds to reschedule marijuana from Schedule I under the Controlled Substances Act, targeting President Trump's executive order to expedite the process. They previously led opposition letters arguing rescheduling undermines anti-drug priorities and economic goals. Similar House efforts and GOP at

OG article by Toluwani Osibamowo January 15, 2026 The Texas Supreme Court heard arguments on whether the Department of State Health Services (DSHS) can classify delta-8 THC as a Schedule I controlled substance. DSHS's 2021 notice reclassified delta-8 and high delta-9 THC hemp products as Schedule I, despite the 2018 Farm Bill legalizing hemp under 0.3% delta-9 THC. Hemp-derived products like delta-8 are sold widely, unlike restricted marijuana. Retailers sued, claiming overr

OG article by Tom Angell January 15, 2026 New Jersey Senate President Nicholas Scutari (D) introduced legislation enabling licensed marijuana businesses to engage in interstate commerce. The bill authorizes the governor to negotiate agreements with other states for commercial cannabis activities between licensed entities, covering both medical and adult-use markets. Implementation hinges on federal shifts, such as explicit legalization of interstate trade, a DOJ memo tolerat

OG article by MJBizDaily Staff January 15, 2026 Texas' medical marijuana program, known as the Texas Compassionate Use Program (TCUP), is positioned for major growth in 2026 after Gov. Greg Abbott signed House Bill 46 in June 2025. This expanded eligibility to include chronic pain and terminal illnesses, with provisions for adding conditions without new laws. Allowed products now feature up to 10 mg THC per dose (max 1,000 mg per package), including oils, topicals, patches,